[1]
M. Romanens, A. Adams, and W. Warmuth, “PROCAM based myocardial infarction risk in relation to global vascular disease risk: observations from the ARCO cohort study”, Swiss Med Wkly, vol. 152, no. 0708, p. w30111, Feb. 2022.